BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 16271955)

  • 1. Chromosomal alterations cause the high rates and wide ranges of drug resistance in cancer cells.
    Li R; Hehlman R; Sachs R; Duesberg P
    Cancer Genet Cytogenet; 2005 Nov; 163(1):44-56. PubMed ID: 16271955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer drug resistance: the central role of the karyotype.
    Duesberg P; Li R; Sachs R; Fabarius A; Upender MB; Hehlmann R
    Drug Resist Updat; 2007; 10(1-2):51-8. PubMed ID: 17387035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer-causing karyotypes: chromosomal equilibria between destabilizing aneuploidy and stabilizing selection for oncogenic function.
    Li L; McCormack AA; Nicholson JM; Fabarius A; Hehlmann R; Sachs RK; Duesberg PH
    Cancer Genet Cytogenet; 2009 Jan; 188(1):1-25. PubMed ID: 19061776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. On the karyotypic origin and evolution of cancer cells.
    Nicholson JM; Duesberg P
    Cancer Genet Cytogenet; 2009 Oct; 194(2):96-110. PubMed ID: 19781442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The chromosomal basis of cancer.
    Duesberg P; Li R; Fabarius A; Hehlmann R
    Cell Oncol; 2005; 27(5-6):293-318. PubMed ID: 16373963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aneuploidy, the primary cause of the multilateral genomic instability of neoplastic and preneoplastic cells.
    Duesberg P; Fabarius A; Hehlmann R
    IUBMB Life; 2004 Feb; 56(2):65-81. PubMed ID: 15085930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specific clones of spontaneously evolving karyotypes generate individuality of cancers.
    Fabarius A; Li R; Yerganian G; Hehlmann R; Duesberg P
    Cancer Genet Cytogenet; 2008 Jan; 180(2):89-99. PubMed ID: 18206533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytogenetic alterations associated with the acquisition of doxorubicin resistance: possible significance of chromosome 7 alterations.
    Slovak ML; Hoeltge GA; Trent JM
    Cancer Res; 1987 Dec; 47(24 Pt 1):6646-52. PubMed ID: 3677098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Defining the steps that lead to cancer: replicative telomere erosion, aneuploidy and an epigenetic maturation arrest of tissue stem cells.
    Stindl R
    Med Hypotheses; 2008; 71(1):126-40. PubMed ID: 18294777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aneuploidy, the somatic mutation that makes cancer a species of its own.
    Duesberg P; Rasnick D
    Cell Motil Cytoskeleton; 2000 Oct; 47(2):81-107. PubMed ID: 11013390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How aneuploidy may cause cancer and genetic instability.
    Duesberg P; Rasnick D; Li R; Winters L; Rausch C; Hehlmann R
    Anticancer Res; 1999; 19(6A):4887-906. PubMed ID: 10697602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytotoxic and cytodifferentiative components of 6-thioguanine resistance in HL-60 cells containing acquired double minute chromosomes.
    Gallagher RE; Ferrari AC; Zulich AW; Yen RW; Testa JR
    Cancer Res; 1984 Jun; 44(6):2642-53. PubMed ID: 6586289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 1p31, 7q21 and 18q21 chromosomal aberrations and candidate genes in acquired vinblastine resistance of human cervical carcinoma KB cells.
    Wang J; Tai LS; Tzang CH; Fong WF; Guan XY; Yang M
    Oncol Rep; 2008 May; 19(5):1155-64. PubMed ID: 18425371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histone deacetylase 1 gene expression and sensitization of multidrug-resistant neuroblastoma cell lines to cytotoxic agents by depsipeptide.
    Keshelava N; Davicioni E; Wan Z; Ji L; Sposto R; Triche TJ; Reynolds CP
    J Natl Cancer Inst; 2007 Jul; 99(14):1107-19. PubMed ID: 17623797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aneuploidy and cancer: from correlation to causation.
    Duesberg P; Li R; Fabarius A; Hehlmann R
    Contrib Microbiol; 2006; 13():16-44. PubMed ID: 16627957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Explaining the high mutation rates of cancer cells to drug and multidrug resistance by chromosome reassortments that are catalyzed by aneuploidy.
    Duesberg P; Stindl R; Hehlmann R
    Proc Natl Acad Sci U S A; 2000 Dec; 97(26):14295-300. PubMed ID: 11121035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Similar chromosomal changes in cisplatin and oxaliplatin-resistant sublines of the H69 SCLC cell line are not associated with platinum resistance.
    Stordal B; Peters G; Davey R
    Genes Chromosomes Cancer; 2006 Dec; 45(12):1094-105. PubMed ID: 16967470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Origin of multidrug resistance in cells with and without multidrug resistance genes: chromosome reassortments catalyzed by aneuploidy.
    Duesberg P; Stindl R; Hehlmann R
    Proc Natl Acad Sci U S A; 2001 Sep; 98(20):11283-8. PubMed ID: 11553793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chromosomal markers associated with metastasis in two colon cancer cell lines established from the same patient.
    Gagos S; Hopwood VL; Iliopoulos D; Kostakis A; Karayannakos P; Yatzides H; Skalkeas GD; Pathak S
    Anticancer Res; 1995; 15(2):369-78. PubMed ID: 7763008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A model for genetic complementation controlling the chromosomal abnormalities and loss of heterozygosity formation in cancer.
    Nestor AL; Hollopeter SL; Matsui SI; Allison D
    Cytogenet Genome Res; 2007; 116(4):235-47. PubMed ID: 17431320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.